Figure 3
(A) Proliferation response of patient CRC09 following immunisation with 105AD7. (B) Proliferation response of patient CRC01 following immunisation with 105AD7. T-cell proliferation was assessed by 3H-labelled thymidine incorporation following 5-day stimulation with either 105AD7 or control human IgG: 
An SI of greater than 2 is considered significant. Arrows denote injection with 105AD7 by intradermal (10 μg) and intramuscular (100 μg on alum) injection.
